|
1
|
Mahmud SM, Bozat-Emre S, Mostaço-Guidolin
LC and Marrie RA: Registry cohort study to determine risk for
multiple sclerosis after vaccination for pandemic influenza A(H1N1)
with Arepanrix, Manitoba, Canada. Emerg Infect Dis. 24:1267–1274.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Fukuda M, Yoshida T, Moroki M, Hirayu N,
Nabeta M, Nakamura A, Uzu H and Takasu O: Influenza A with
hemorrhagic shock and encephalopathy syndrome in an adult: A case
report. Medicine (Baltimore). 98:e150122019. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Siegers JY, van de Bildt MWG, Lin Z,
Leijten LM, Lavrijssen RAM, Bestebroer T, Spronken MIJ, De Zeeuw
CI, Gao Z, Schrauwen EJA, et al: Viral factors important for
efficient replication of influenza A viruses in cells of the
central nervous system. J Virol. 93:e02273–18. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ninove L, Daniel L, Gallou J, Cougard PA,
Charpentier A, Viard L, Roquelaure B, Paquis-Flucklinger V, de
Lamballerie X, Zandotti C and Charrel RN: Fatal case of Reye's
syndrome associated with H3N2 influenza virus infection and
salicylate intake in a 12-year-old patient. Clin Microbiol Infect.
17:95–97. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Francis JR, Richmond P, Robins C, Lindsay
K, Levy A, Effler PV, Borland M and Blyth CC: An observational
study of febrile seizures: The importance of viral infection and
immunization. BMC Pediatr. 16:2022016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Cárdenas G, Soto-Hernández JL, Díaz-Alba
A, Ugalde Y, Mérida-Puga J, Rosetti M and Sciutto E: Neurological
events related to influenza A (H1N1) pdm09. Influenza Other Respir
Viruses. 8:339–346. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Tin SS and Wiwanitkit V: Neurological
complications after H1N1 influenza vaccination. Arq Neuropsiquiatr.
72:9772014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Guo CY, Tang YG, Qi ZL, Liu Y, Zhao XR,
Huo XP, Li Y, Feng Q, Zhao PH, Wang X, et al: Development and
characterization of a panel of cross-reactive monoclonal antibodies
generated using H1N1 influenza virus. Immunobiology. 220:941–946.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yamamoto M, Cid E and Yamamoto F:
Molecular genetic basis of the human Forssman glycolipid antigen
negativity. Sci Rep. 2:9752012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang JJ, Yang GX, Zhang WC, Lu L,
Tsuneyama K, Kronenberg M, Véla JL, Lopez-Hoyos M, He XS, Ridgway
WM, et al: Escherichia coli infection induces autoimmune
cholangitis and anti-mitochondrial antibodies in non-obese diabetic
(NOD).B6 (Idd10/Idd18) mice. Clin Exp Immunol. 175:192–201. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Coppieters KT and von Herrath M: Antibody
cross-reactivity and the viral aetiology of type 1 diabetes. J
Pathol. 230:1–3. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Guo CY, Zhang HX, Zhang JJ, Sun LJ, Li HJ,
Liang DY, Feng Q, Li Y, Feng YM, Xie X and Hu J: Localization
analysis of heterophilic antigen epitopes of H1N1 influenza virus
hemagglutinin. Virol Sin. 34:306–314. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sun L, Li H, Sun J, Guo C, Feng Y, Li Y,
Zhao X, Xie X and Hu J: Antibodies against H1N1 influenza virus
hemagglutinin cross-react with prohibitin. Biochem Biophys Res
Commun. 513:446–451. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Levin MC, Lee SM, Kalume F, Morcos Y,
Dohan FC Jr, Hasty KA, Callaway JC, Zunt J, Desiderio D and Stuart
JM: Autoimmunity due to molecular mimicry as a cause of
neurological disease. Nat Med. 8:509–513. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yang L, Tu JL and Xiong YS:
Influenza-related central nervous system damage. Chin J Neurol.
43:737–738. 2010.
|
|
16
|
Ahmed SS, Volkmuth W, Duca J, Corti L,
Pallaoro M, Pezzicoli A, Karle A, Rigat F, Rappuoli R, Narasimhan
V, et al: Antibodies to influenza nucleoprotein cross-react with
human hypocretin receptor 2. Sci Transl Med. 7:294ra1052015.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sarkanen TO, Alakuijala APE, Dauvilliers
YA and Partinen MM: Incidence of narcolepsy after H1N1 influenza
and vaccinations: Systematic review and meta-analysis. Sleep Med
Rev. 38:177–186. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wekerle H: Vaccination and narcolepsy:
Immune link found? Sci Transl Med. 7:1–3. 2015. View Article : Google Scholar
|
|
19
|
Krecic AM and Swanson MS: hnRNP complexes:
Composition, structure, and function. Curr Opin Cell Biol.
11:363–371. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Levin MC, Lee SM, Gardner LA, Shin Y,
Douglas JN and Salapa H: Autoantibodies to heterogeneous nuclear
ribonuclear protein A1 (hnRNPA1) cause altered ‘ribostasis’ and
neurodegeneration; the legacy of HAM/TSP as a model of progressive
multiple sclerosis. J Neuroimmunol. 304:56–62. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Douglas JN, Gardner LA, Salapa HE, Lalor
SJ, Lee S, Segal BM, Sawchenko PE and Levin MC: Antibodies to the
RNA-binding protein hnRNP A1 contribute to neurodegeneration in a
model of central nervous system autoimmune inflammatory disease. J
Neuroinflammation. 13:1782016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sueoka E, Yukitake M, Iwanaga K, Sueoka N,
Aihara T and Kuroda Y: Autoantibodies against heterogeneous nuclear
ribonucleoprotein B1 in CSF of MS patients. Ann Neurol. 56:778–786.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lee S, Xu L, Shin Y, Gardner L, Hartzes A,
Dohan FC, Raine C, Homayouni R and Levin MC: A potential link
between autoimmunity and neurodegeneration in immune-mediated
neurological disease. J Neuroimmunol. 235:56–69. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Mishra S, Murphy LC and Murphy LJ: The
prohibitins: Emerging roles in diverse functions. J Cell Mol Med.
10:353–363. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lee SM, Dunnavant FD, Jang H, Zunt J and
Levin MC: Autoantibodies that recognize functional domains of
hnRNPA1 implicate molecular mimicry in the pathogenesis of
neurological disease. Neurosci Lett. 401:188–193. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Gauntt CJ, Arizpe HM, Higdon AL, Wood HJ,
Bowers DF, Rozek MM and Crawley R: Molecular mimicry,
anti-coxsackievirus B3 neutralizing monoclonal antibodies, and
myocarditis. J Immunol. 154:2983–2995. 1995.PubMed/NCBI
|
